taxonomy (4)
protein (68)
source (11)
structure (11)
composition (1)
disease (5)
reference (15)
site (83)
peptide (74)
- Homo sapiens (Human)
- Mus musculus (House mouse)
- Bufo bufo (European toad)
- Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
Taxonomy
- Asporin / Homo sapiens Q9BXN1
- Attractin / Homo sapiens O75882
- Biglycan / Homo sapiens P21810
- Calumenin / Homo sapiens O43852
- Calumenin, isoform CRA_a / Homo sapiens
- Chymotrypsin-like elastase family member 3B / Homo sapiens P08861
- Clusterin / Homo sapiens P10909
- Collagen alpha-1(XII) chain / Homo sapiens Q99715
- Collagen alpha-2(VI) chain / Homo sapiens P12110
- Fibronectin / Homo sapiens P02751
- Gamma-glutamyl hydrolase / Homo sapiens Q92820
- Golgi apparatus protein 1 / Homo sapiens Q92896
- Immunoglobulin heavy constant gamma 1 / Homo sapiens P01857
- Immunoglobulin heavy constant gamma 2 / Homo sapiens P01859
- Immunoglobulin heavy constant gamma 4 / Homo sapiens P01861
- Immunoglobulin heavy constant mu / Homo sapiens P01871
- Immunoglobulin j chain / Homo sapiens P01591
- Laminin subunit alpha-4 / Homo sapiens Q16363
- Lumican / Homo sapiens P51884
- Lysosomal Pro-X carboxypeptidase / Homo sapiens P42785
- Lysosome-associated membrane glycoprotein 1 / Homo sapiens P11279
- Lysosome-associated membrane glycoprotein 2 / Homo sapiens P13473
- Olfactomedin-like protein 3 / Homo sapiens Q9NRN5
- Periostin / Homo sapiens Q15063
- Plexin-B2 / Homo sapiens O15031
- Prolactin-inducible protein / Homo sapiens P12273
- Recombinant mature angiotensin-converting enzyme 2 / Homo sapiens Q9BYF1
- Reticulocalbin-1 / Homo sapiens Q15293
- Reticulocalbin-3 / Homo sapiens Q96D15
- RNA polymerase II elongation factor ELL2 / Homo sapiens O00472
- Serotransferrin / Homo sapiens P02787
- Serpin h1 / Homo sapiens P50454
- Sparc / Homo sapiens P09486
- Thrombospondin-1 / Homo sapiens P07996
- Thyroglobulin / Homo sapiens P01266
- Transmembrane emp24 domain-containing protein 9 / Homo sapiens Q9BVK6
- Uncharacterized protein from Fluid / Homo sapiens
- Uncharacterized protein from Urine / Homo sapiens
- Uncharacterized protein KIAA0232 / Homo sapiens Q92628
- Unspecified mucin / Homo sapiens
- Uromodulin / Homo sapiens P07911
- Zinc-alpha-2-glycoprotein / Homo sapiens P25311
- BTB/POZ domain-containing protein 17 / Mus musculus Q9DB72
- Cell adhesion molecule 4 / Mus musculus Q8R464
- Dipeptidyl aminopeptidase-like protein 6 / Mus musculus Q9Z218
- Hepatocyte cell adhesion molecule / Mus musculus Q640R3
- Hyaluronan and proteoglycan link protein 1 / Mus musculus Q9QUP5
- Integrin alpha-V / Mus musculus P43406
- Integrin beta-1 / Mus musculus P09055
- Intercellular adhesion molecule 5 / Mus musculus Q60625
- Isoform 2 of Cell adhesion molecule 2 / Mus musculus Q8BLQ9-2
- Limbic system-associated membrane protein / Mus musculus Q8BLK3
- Metabotropic glutamate receptor 3 / Mus musculus Q9QYS2
- Neuronal cell adhesion molecule / Mus musculus Q810U4
- Neuronal pentraxin-1 / Mus musculus Q62443
- Noelin / Mus musculus O88998
- Phospholipase D3 / Mus musculus O35405
- Plexin-B1 / Mus musculus Q8CJH3
- Prolow-density lipoprotein receptor-related protein 1 / Mus musculus Q91ZX7
- Receptor-type tyrosine-protein phosphatase zeta / Mus musculus B9EKR1
- Serine/arginine-rich splicing factor 3 / Mus musculus P84104
- Sortilin-related receptor / Mus musculus O88307
- Tenascin-r / Mus musculus Q8BYI9
- Thy-1 membrane glycoprotein / Mus musculus P01831
- Vascular cell adhesion protein 1 / Mus musculus P29533
- Zinc transporter ZIP14 / Mus musculus Q75N73
- Mucin / Bufo bufo
- Recombinant Spike glycoprotein (FreeStyle 293-F) / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV) P0DTC2
Protein
- Blood Serum (UBERON_0001977)
- Brain (UBERON_0000955)
- Mammary Gland (UBERON_0001911)
- Mucosa of Stomach (UBERON_0001199)
- Ovary (UBERON_0000992)
- Pancreas (UBERON_0001264)
- Stomach (UBERON_0000945)
- Urine (UBERON_0001088)
- FreeStyle 293-F (CVCL_D603)
- HEK293 (CVCL_0045)
- Egg Cell Jelly Coat
Source
- N-Linked / Complex / Fuc(a1-3)[Gal(b1-4)]GlcNAc(b1-2)Man(a1-6)[GlcNAc(b1-4)][Man(a1-3)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc
- N-Linked / Complex / Fuc(a1-?)[Gal(b1-?)]GlcNAc(b1-2)Man(a1-3)[GlcNAc(b1-2)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc
- N-Linked / No-core / Fuc(a1-2)Gal(b1-4)GlcNAc(b1-3)Gal(b1-4)GlcNAc(b1-2)Man(a1-6)Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc
- N-Linked / No-core / Fuc(a1-3)[Gal(b1-4)]GlcNAc(b1-3)Gal(b1-4)GlcNAc(b1-2)Man(a1-6)Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc
- N-Linked / Undefined core / Man(a1-3)[Man(a1-6)]Man(b1-4)GlcNAc(b1-4)GlcNAc + " + Hex + 2x HexNAc + 2x Fuc "
- O-Linked / Core 1 / Fuc(a1-2)Gal(b1-?)GlcNAc(b1-3)[Fuc(a1-2)Gal(b1-?)GlcNAc(b1-6)]Gal(b1-?)GlcNAc(b1-3)Gal(b1-3)GalNAc
- O-Linked / Core 1 / Fuc(a1-3)[Gal(b1-4)]GlcNAc(b1-6)[Fuc(a1-4)[Gal(b1-3)]GlcNAc(b1-3)]Gal(b1-3)GlcNAc(b1-3)Gal(b1-3)GalNAc
- O-Linked / Core 2 / Fuc(a1-2)Gal(b1-?)GlcNAc(b1-3)[Fuc(a1-2)Gal(b1-?)GlcNAc(b1-6)]Gal(b1-3)[Gal(b1-4)GlcNAc(b1-6)]GalNAc
- O-Linked / Core 2 / Fuc(a1-2)Gal(b1-?)GlcNAc(b1-?)[Fuc(a1-2)[GalNAc(a1-3)]Gal(b1-?)GlcNAc(b1-?)]Gal(b1-3)[Gal(b1-6)]GalNAc
- O-Linked / Core 2 / Fuc(a1-4)[Gal(b1-3)]GlcNAc(b1-3)Gal(b1-4)GlcNAc(b1-6)[Fuc(a1-4)[Gal(b1-3)]GlcNAc(b1-3)Gal(b1-3)]GalNAc
- O-Linked / Core 2 / Gal(a1-3)GalNAc(a1-3)[Fuc(a1-2)]Gal(b1-4)GlcNAc(b1-6)[Gal(a1-3)GalNAc(a1-3)[Fuc(a1-2)]Gal(b1-3)]GalNAc
Reported structure
- Hex:4 HexNAc:4 dHex:2 (avg mass : 1771.6509 )
Composition
- Cancer, breast (DOID:1612)
- COVID-19 (DOID:0080600)
- Fucosidosis (DOID:14500)
- Ovarian cyst (DOID:5119)
- Prostate cancer (DOID:10283)
Disease
- Site-specific glycan analysis of the SARS-CoV-2 spike (2020 - Yasunori Watanabe, Joel D. Allen, Daniel Wrapp, Jason S. McLellan, Max Crispin) / Status : Unreviewed
- Comprehensive characterization of N- and O- glycosylation of SARS-CoV-2 human receptor angiotensin converting enzyme 2. (2020 - Asif Shajahan, Stephanie Archer-Hartmann, Nitin T. Supekar, Anne S. Gleinich, Christian Heiss, and Parastoo Azadi) / Status : Reviewed
- Capturing site-specific heterogeneity with large-scale N-glycoproteome analysis (2019 - Nicholas M. Riley, Alexander S. Hebert, Michael S. Westphall & Joshua J. Coon ) / Status : Unreviewed
- Reanalysis of global proteomic and phosphoproteomic data identified a large number of glycopeptides (2018 - Yingwei Hu, Punit Shah, David J. Clark, Minghui Ao, Hui Zhang) / Status : Unreviewed
- Site-Specific Profiling of Serum Glycoproteins Using N-Linked Glycan and Glycosite Analysis Revealing Atypical N-Glycosylation Sites on Albumin and α-1B-Glycoprotein (2018 - Shisheng Sun, Yingwei Hu, Li Jia, Shadi Toghi Eshghi, Yang Liu, Punit Shah, Hui Zhang) / Status : Unreviewed
- Distinct urinary glycoprotein signatures in prostate cancer patients (2018 - Rebeca Kawahara, Fabio Ortega, Livia Rosa-Fernandes, Vanessa Guimarães, Daniel Quina, Willian Nahas, Veit Schwämmle, Miguel Srougi, Katia R.M. Leite, Morten Thaysen-Andersen, Martin R. Larsen and Giuseppe Palmisano) / Status : Unreviewed
- Efficient and accurate glycopeptide identification pipeline for high-throughput site-specific N-glycosylation analysis (2014 - Liu M, Zhang Y, Chen Y, Yan G, Shen C, Cao J, Zhou X, Liu X, Zhang L, Shen H, Lu H, He F, Yang P) / Status : Reviewed
- Glycosylation of a CNS-specific extracellular matrix glycoprotein, tenascin-R, is dominated by O-linked sialylated glycans and "brain-type" neutral N-glycans. (1999 - Zamze S, Harvey D, Pesheva P, Mattu T, Schachner M, Dwek R, Wing D) / Status : Reviewed
- Structural analysis of hexa to dodecaoligosaccharide-alditols released by reductive beta-elimination from oviducal mucins of Bufo bufo. (1997 - Morelle W, Strecker G) / Status : Reviewed
- Carbohydrate structure of human pancreatic elastase 1. (1991 - Wendorf P, Linder D, Sziegoleit A, Geyer R) / Status : Reviewed
- Characterization and 400-MHz 1H-NMR analysis of urinary fucosyl glycoasparagines in fucosidosis. (1991 - Michalski J, Wieruszeski J, Alonso C, Cache P, Montreuil J, Strecker G) / Status : Reviewed
- Structural characterization of neutral oligosaccharides of human H+Leb+ gastric mucin. (1984 - Slomiany B, Zdebska E, Slomiany A) / Status : Reviewed
- Structures of the neutral oligosaccharides isolated from A-active human gastric mucin. (1984 - Slomiany A, Zdebska E, Slomiany BL) / Status : Reviewed
- Structures of oligosaccharides cleaved by base-borohydride from an I, H and Lea active ovarian cyst glycoprotein. (1984 - Tanaka M, Dube V, Anderson B) / Status : Reviewed
- Structures of oligosaccharides produced by base--borohydride degradation of human ovarian cyst blood group H, Le-b and Le-a active glycoproteins. (1973 - Rovis L, Anderson B, Kabat E, Gruenzo F, Liao J) / Status : Reviewed
Reference
- Asporin / Homo sapiens
- Attractin / Homo sapiens
- Biglycan / Homo sapiens
- Calumenin / Homo sapiens
- Calumenin, isoform CRA_a / Homo sapiens
- Chymotrypsin-like elastase family member 3B / Homo sapiens
- Clusterin / Homo sapiens
- Collagen alpha-1(XII) chain / Homo sapiens
- Collagen alpha-2(VI) chain / Homo sapiens
- Fibronectin / Homo sapiens
- Gamma-glutamyl hydrolase / Homo sapiens
- Golgi apparatus protein 1 / Homo sapiens
- Immunoglobulin heavy constant gamma 1 / Homo sapiens
- Immunoglobulin heavy constant gamma 2 / Homo sapiens
- Immunoglobulin heavy constant gamma 4 / Homo sapiens
- Immunoglobulin heavy constant mu / Homo sapiens
- Immunoglobulin j chain / Homo sapiens
- Laminin subunit alpha-4 / Homo sapiens
- Lumican / Homo sapiens
- Lysosomal Pro-X carboxypeptidase / Homo sapiens
- Lysosome-associated membrane glycoprotein 1 / Homo sapiens
- Lysosome-associated membrane glycoprotein 2 / Homo sapiens
- Olfactomedin-like protein 3 / Homo sapiens
- Periostin / Homo sapiens
- Plexin-B2 / Homo sapiens
- Prolactin-inducible protein / Homo sapiens
-
Recombinant mature angiotensin-converting enzyme 2 / Homo sapiens
- Undefined site
- Reticulocalbin-1 / Homo sapiens
- Reticulocalbin-3 / Homo sapiens
- RNA polymerase II elongation factor ELL2 / Homo sapiens
- Serotransferrin / Homo sapiens
- Serpin h1 / Homo sapiens
- Sparc / Homo sapiens
- Thrombospondin-1 / Homo sapiens
- Thyroglobulin / Homo sapiens
- Transmembrane emp24 domain-containing protein 9 / Homo sapiens
-
Uncharacterized protein from Fluid / Homo sapiens
- Undefined site
-
Uncharacterized protein from Urine / Homo sapiens
- Undefined site
- Uncharacterized protein KIAA0232 / Homo sapiens
-
Unspecified mucin / Homo sapiens
- Undefined site
- Uromodulin / Homo sapiens
- Zinc-alpha-2-glycoprotein / Homo sapiens
- BTB/POZ domain-containing protein 17 / Mus musculus
- Cell adhesion molecule 4 / Mus musculus
- Dipeptidyl aminopeptidase-like protein 6 / Mus musculus
- Hepatocyte cell adhesion molecule / Mus musculus
- Hyaluronan and proteoglycan link protein 1 / Mus musculus
- Integrin alpha-V / Mus musculus
- Integrin beta-1 / Mus musculus
- Intercellular adhesion molecule 5 / Mus musculus
- Isoform 2 of Cell adhesion molecule 2 / Mus musculus
- Limbic system-associated membrane protein / Mus musculus
- Metabotropic glutamate receptor 3 / Mus musculus
- Neuronal cell adhesion molecule / Mus musculus
- Neuronal pentraxin-1 / Mus musculus
- Noelin / Mus musculus
- Phospholipase D3 / Mus musculus
- Plexin-B1 / Mus musculus
- Prolow-density lipoprotein receptor-related protein 1 / Mus musculus
- Receptor-type tyrosine-protein phosphatase zeta / Mus musculus
- Serine/arginine-rich splicing factor 3 / Mus musculus
- Sortilin-related receptor / Mus musculus
-
Tenascin-r / Mus musculus
- Undefined site
- Thy-1 membrane glycoprotein / Mus musculus
- Vascular cell adhesion protein 1 / Mus musculus
- Zinc transporter ZIP14 / Mus musculus
-
Mucin / Bufo bufo
- Undefined site
- Recombinant Spike glycoprotein (FreeStyle 293-F) / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
Reported glycosite
- QCVNLTTR (8aa)
- VYVGNLGNNGNK (12aa)
- LELNLTDSENATCLYAK (17aa)
- HENNTKDNSIQHEFSLTR (18aa)
- VVRPDSEIGERPPEDNQSFQYDHEAFIGK (29aa)
- GGNVTLPCK (9aa)
- IIVPINNRENISDPTSPIR (19aa)
- FHAIHVSGTNGTKRF (15aa)
- SLLDHLHVGVGRDNVSQPK (19aa)
- VLTLANFTTK (10aa)
- TFYWDFYTNR (10aa)
- VCSNDNK (7aa)
- TQSLLIVNNATNVVIK (16aa)
- LHINHNNLTESVGPLPK (17aa)
- FTFTSHTPGEHQICIHSNSTK (21aa)
- FGCEIENNRSSGAFWK (16aa)
- NVTYGTYIDDPDPDDGFNYK (20aa)
- NVTYGTYIDDPDPDDGFNYK (20aa)
- NATYGYVIDDPDPDDGFNYK (20aa)
- NATYGHYAPGEEFHDVEDAETYKK (24aa)
- YHKNNKSWMESEF (13aa)
- CGLVPVLAENYNKSDNCEDTPEAGYFAVAVVK (32aa)
- CGLVPVLAENYNKSDNCEDTPEAGYFAVAVVK (32aa)
- SSANNCTFEYVSQPF (15aa)
- EEQFNSTFR (9aa)
- IYVIDGTQNDTAFVFPR (17aa)
- DGKPLLNDSR (10aa)
- VNTLEEGKGGPKNDTEER (18aa)
- NTTGFK (6aa)
- VDHESLNATPQVAMQVLEIHYTPSVK (26aa)
- NTTISVHPSTR (11aa)
- ELGVVMYNCSCLAR (14aa)
- KDNTTVTR (8aa)
- WNRGNESLPER (11aa)
- MIENGSISFIPTIR (14aa)
- ACAGGYYVYNLTAPPECHLAYCTDPSSVEGTCEECSIDEDCK (42aa)
- ITDIENGSIANIPR (14aa)
- LGVTNASLVLFRPGSVR (17aa)
- ALIYQFSPIYTGNISSFQQCYIFD (24aa)
- FFHVNGSAFLPR (12aa)
- ALIYQFSPIYTGNISSF (17aa)
- RFPNIT (6aa)
- GEVFNATRF (9aa)
- NATRF (5aa)
- MINTSSIIEQINEQFNWVSR (20aa)
- VSCPIMPCSNATVPDGECCPR (21aa)
- IANITQGEDQYYIR (14aa)
- GFFCDAALDVDGETLRKNQSSELR (24aa)
- NISSHTNIVFSNGELDPWSGGGVTK (25aa)
- INFTAPFNPNK (11aa)
- ALYAWNNGHQTLYNVTLFHVIR (22aa)
- LNNSSPNSSGGVK (13aa)
- SDVPNTSPNSTSQHVAEFETER (22aa)
- CEGPGVPTVTVHNTTDKR (18aa)
- SCVAVTSAQPQNMSRR (16aa)
- DQCIVDDITYNVNDTFHK (18aa)
- EVNDTLLVNELK (12aa)
- FSTDKDHLVVSDVKDDDGGTYTCTANTTLDSASASAVLR (39aa)
- KDTCAQECSHFNLTK (15aa)
- TPHATCFNGEDFDRPVVVSNCSCTR (25aa)
- RTPHATCFNGEDFDRPVVVSNCSCTR (26aa)
- NFTIS (5aa)
- TCSPWSHSEETRSDNETLNIQFEESTQFNAEDINYVVPR (39aa)
- NMTLFSDLVAEK (12aa)
- NDTLQEAK (8aa)
- DFGGFNFSQILPDPSKPSK (19aa)
- INVSYWCWEDMSPFTNSLLQWMPSEPSDAGFCGILSEPSTR (41aa)
- IKTPEKNDTAAAGQGER (17aa)
- VPAQEKNF (8aa)
- NGTHWFV (7aa)
- QHVVPEKFEEPCLVNSSHLLMCR (23aa)
- GCKDNATDSVPLR (13aa)
- MIEAYNITEK (10aa)
- EAGNITTDGYEIIGK (15aa)
- MHLNGSNVQVLHR (13aa)
- RMHLNGSNVQVLHR (14aa)
Mass spectrometry observed peptide
-
- N-Linked / Complex (avg mass : 1771.6509)
- Brain (UBERON_0000955)
-
Tenascin-r / Mus musculus
- Undefined site
-
- N-Linked / Complex (avg mass : 1771.6509)
- Pancreas (UBERON_0001264)
- Chymotrypsin-like elastase family member 3B / Homo sapiens
-
- N-Linked / No-core (avg mass : 1771.6509)
- Urine (UBERON_0001088)
- Fucosidosis (DOID:14500)
-
Uncharacterized protein from Urine / Homo sapiens
- Undefined site
-
- N-Linked / No-core (avg mass : 1771.6509)
- Urine (UBERON_0001088)
- Fucosidosis (DOID:14500)
-
Uncharacterized protein from Urine / Homo sapiens
- Undefined site
-
- N-Linked / Undefined core (avg mass : 1771.6509)
- HEK293 (CVCL_0045)
-
Recombinant mature angiotensin-converting enzyme 2 / Homo sapiens
- Undefined site
-
- O-Linked / Core 1 (avg mass : 1771.6509)
-
Unspecified mucin / Homo sapiens
- Undefined site
-
- O-Linked / Core 1 (avg mass : 1771.6509)
- Ovary (UBERON_0000992)
- Ovarian cyst (DOID:5119)
-
Uncharacterized protein from Fluid / Homo sapiens
- Undefined site
-
- O-Linked / Core 2 (avg mass : 1771.6509)
-
Unspecified mucin / Homo sapiens
- Undefined site
-
- O-Linked / Core 2 (avg mass : 1771.6509)
- Stomach (UBERON_0000945)
-
Unspecified mucin / Homo sapiens
- Undefined site
-
- O-Linked / Core 2 (avg mass : 1771.6509)
- Ovary (UBERON_0000992)
- Ovarian cyst (DOID:5119)
-
Unspecified mucin / Homo sapiens
- Undefined site
-
- O-Linked / Core 2 (avg mass : 1771.6509)
- Egg Cell Jelly Coat
-
Mucin / Bufo bufo
- Undefined site
-
- Hex:4 HexNAc:4 dHex:2 / N-Linked (avg mass : 1771.6509)
- Blood Serum (UBERON_0001977)
- Brain (UBERON_0000955)
- Mammary Gland (UBERON_0001911)
- Urine (UBERON_0001088)
- FreeStyle 293-F (CVCL_D603)
- N-Linked / Complex / Fuc(a1-3)[Gal(b1-4)]GlcNAc(b1-2)Man(a1-6)[GlcNAc(b1-4)][Man(a1-3)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc
- N-Linked / Complex / Fuc(a1-?)[Gal(b1-?)]GlcNAc(b1-2)Man(a1-3)[GlcNAc(b1-2)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc
- N-Linked / No-core / Fuc(a1-2)Gal(b1-4)GlcNAc(b1-3)Gal(b1-4)GlcNAc(b1-2)Man(a1-6)Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc
- N-Linked / No-core / Fuc(a1-3)[Gal(b1-4)]GlcNAc(b1-3)Gal(b1-4)GlcNAc(b1-2)Man(a1-6)Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc
- N-Linked / Undefined core / Man(a1-3)[Man(a1-6)]Man(b1-4)GlcNAc(b1-4)GlcNAc + " + Hex + 2x HexNAc + 2x Fuc "
- Site-specific glycan analysis of the SARS-CoV-2 spike (2020 - Yasunori Watanabe, Joel D. Allen, Daniel Wrapp, Jason S. McLellan, Max Crispin) / Status : Unreviewed
- Capturing site-specific heterogeneity with large-scale N-glycoproteome analysis (2019 - Nicholas M. Riley, Alexander S. Hebert, Michael S. Westphall & Joshua J. Coon ) / Status : Unreviewed
- Site-Specific Profiling of Serum Glycoproteins Using N-Linked Glycan and Glycosite Analysis Revealing Atypical N-Glycosylation Sites on Albumin and α-1B-Glycoprotein (2018 - Shisheng Sun, Yingwei Hu, Li Jia, Shadi Toghi Eshghi, Yang Liu, Punit Shah, Hui Zhang) / Status : Unreviewed
- Reanalysis of global proteomic and phosphoproteomic data identified a large number of glycopeptides (2018 - Yingwei Hu, Punit Shah, David J. Clark, Minghui Ao, Hui Zhang) / Status : Unreviewed
- Distinct urinary glycoprotein signatures in prostate cancer patients (2018 - Rebeca Kawahara, Fabio Ortega, Livia Rosa-Fernandes, Vanessa Guimarães, Daniel Quina, Willian Nahas, Veit Schwämmle, Miguel Srougi, Katia R.M. Leite, Morten Thaysen-Andersen, Martin R. Larsen and Giuseppe Palmisano) / Status : Unreviewed
- Efficient and accurate glycopeptide identification pipeline for high-throughput site-specific N-glycosylation analysis (2014 - Liu M, Zhang Y, Chen Y, Yan G, Shen C, Cao J, Zhou X, Liu X, Zhang L, Shen H, Lu H, He F, Yang P) / Status : Reviewed
- Asporin / Homo sapiens
- Attractin / Homo sapiens
- Biglycan / Homo sapiens
- Calumenin / Homo sapiens
- Calumenin, isoform CRA_a / Homo sapiens
- Clusterin / Homo sapiens
- Collagen alpha-1(XII) chain / Homo sapiens
- Collagen alpha-2(VI) chain / Homo sapiens
- Fibronectin / Homo sapiens
- Gamma-glutamyl hydrolase / Homo sapiens
- Golgi apparatus protein 1 / Homo sapiens
- Immunoglobulin heavy constant gamma 1 / Homo sapiens
- Immunoglobulin heavy constant gamma 2 / Homo sapiens
- Immunoglobulin heavy constant gamma 4 / Homo sapiens
- Immunoglobulin heavy constant mu / Homo sapiens
- Immunoglobulin j chain / Homo sapiens
- Laminin subunit alpha-4 / Homo sapiens
- Lumican / Homo sapiens
- Lysosomal Pro-X carboxypeptidase / Homo sapiens
- Lysosome-associated membrane glycoprotein 1 / Homo sapiens
- Lysosome-associated membrane glycoprotein 2 / Homo sapiens
- Olfactomedin-like protein 3 / Homo sapiens
- Periostin / Homo sapiens
- Plexin-B2 / Homo sapiens
- Prolactin-inducible protein / Homo sapiens
- Reticulocalbin-1 / Homo sapiens
- Reticulocalbin-3 / Homo sapiens
- RNA polymerase II elongation factor ELL2 / Homo sapiens
- Serotransferrin / Homo sapiens
- Serpin h1 / Homo sapiens
- Sparc / Homo sapiens
- Thrombospondin-1 / Homo sapiens
- Thyroglobulin / Homo sapiens
- Transmembrane emp24 domain-containing protein 9 / Homo sapiens
- Uncharacterized protein KIAA0232 / Homo sapiens
- Uromodulin / Homo sapiens
- Zinc-alpha-2-glycoprotein / Homo sapiens
- BTB/POZ domain-containing protein 17 / Mus musculus
- Cell adhesion molecule 4 / Mus musculus
- Dipeptidyl aminopeptidase-like protein 6 / Mus musculus
- Hepatocyte cell adhesion molecule / Mus musculus
- Hyaluronan and proteoglycan link protein 1 / Mus musculus
- Integrin alpha-V / Mus musculus
- Integrin beta-1 / Mus musculus
- Intercellular adhesion molecule 5 / Mus musculus
- Isoform 2 of Cell adhesion molecule 2 / Mus musculus
- Limbic system-associated membrane protein / Mus musculus
- Metabotropic glutamate receptor 3 / Mus musculus
- Neuronal cell adhesion molecule / Mus musculus
- Neuronal pentraxin-1 / Mus musculus
- Noelin / Mus musculus
- Phospholipase D3 / Mus musculus
- Plexin-B1 / Mus musculus
- Prolow-density lipoprotein receptor-related protein 1 / Mus musculus
- Receptor-type tyrosine-protein phosphatase zeta / Mus musculus
- Serine/arginine-rich splicing factor 3 / Mus musculus
- Sortilin-related receptor / Mus musculus
- Thy-1 membrane glycoprotein / Mus musculus
- Vascular cell adhesion protein 1 / Mus musculus
- Zinc transporter ZIP14 / Mus musculus
- Recombinant Spike glycoprotein (FreeStyle 293-F) / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
- QCVNLTTR (8aa)
- VYVGNLGNNGNK (12aa)
- LELNLTDSENATCLYAK (17aa)
- HENNTKDNSIQHEFSLTR (18aa)
- VVRPDSEIGERPPEDNQSFQYDHEAFIGK (29aa)
- GGNVTLPCK (9aa)
- IIVPINNRENISDPTSPIR (19aa)
- FHAIHVSGTNGTKRF (15aa)
- SLLDHLHVGVGRDNVSQPK (19aa)
- VLTLANFTTK (10aa)
- TFYWDFYTNR (10aa)
- VCSNDNK (7aa)
- TQSLLIVNNATNVVIK (16aa)
- LHINHNNLTESVGPLPK (17aa)
- FTFTSHTPGEHQICIHSNSTK (21aa)
- FGCEIENNRSSGAFWK (16aa)
- NVTYGTYIDDPDPDDGFNYK (20aa)
- NVTYGTYIDDPDPDDGFNYK (20aa)
- NATYGYVIDDPDPDDGFNYK (20aa)
- NATYGHYAPGEEFHDVEDAETYKK (24aa)
- YHKNNKSWMESEF (13aa)
- CGLVPVLAENYNKSDNCEDTPEAGYFAVAVVK (32aa)
- CGLVPVLAENYNKSDNCEDTPEAGYFAVAVVK (32aa)
- SSANNCTFEYVSQPF (15aa)
- EEQFNSTFR (9aa)
- IYVIDGTQNDTAFVFPR (17aa)
- DGKPLLNDSR (10aa)
- VNTLEEGKGGPKNDTEER (18aa)
- NTTGFK (6aa)
- VDHESLNATPQVAMQVLEIHYTPSVK (26aa)
- NTTISVHPSTR (11aa)
- ELGVVMYNCSCLAR (14aa)
- KDNTTVTR (8aa)
- WNRGNESLPER (11aa)
- MIENGSISFIPTIR (14aa)
- ACAGGYYVYNLTAPPECHLAYCTDPSSVEGTCEECSIDEDCK (42aa)
- ITDIENGSIANIPR (14aa)
- LGVTNASLVLFRPGSVR (17aa)
- ALIYQFSPIYTGNISSFQQCYIFD (24aa)
- FFHVNGSAFLPR (12aa)
- ALIYQFSPIYTGNISSF (17aa)
- RFPNIT (6aa)
- GEVFNATRF (9aa)
- NATRF (5aa)
- MINTSSIIEQINEQFNWVSR (20aa)
- VSCPIMPCSNATVPDGECCPR (21aa)
- IANITQGEDQYYIR (14aa)
- GFFCDAALDVDGETLRKNQSSELR (24aa)
- NISSHTNIVFSNGELDPWSGGGVTK (25aa)
- INFTAPFNPNK (11aa)
- ALYAWNNGHQTLYNVTLFHVIR (22aa)
- LNNSSPNSSGGVK (13aa)
- SDVPNTSPNSTSQHVAEFETER (22aa)
- CEGPGVPTVTVHNTTDKR (18aa)
- SCVAVTSAQPQNMSRR (16aa)
- DQCIVDDITYNVNDTFHK (18aa)
- EVNDTLLVNELK (12aa)
- FSTDKDHLVVSDVKDDDGGTYTCTANTTLDSASASAVLR (39aa)
- KDTCAQECSHFNLTK (15aa)
- TPHATCFNGEDFDRPVVVSNCSCTR (25aa)
- RTPHATCFNGEDFDRPVVVSNCSCTR (26aa)
- NFTIS (5aa)
- TCSPWSHSEETRSDNETLNIQFEESTQFNAEDINYVVPR (39aa)
- NMTLFSDLVAEK (12aa)
- NDTLQEAK (8aa)
- DFGGFNFSQILPDPSKPSK (19aa)
- INVSYWCWEDMSPFTNSLLQWMPSEPSDAGFCGILSEPSTR (41aa)
- IKTPEKNDTAAAGQGER (17aa)
- VPAQEKNF (8aa)
- NGTHWFV (7aa)
- QHVVPEKFEEPCLVNSSHLLMCR (23aa)
- GCKDNATDSVPLR (13aa)
- MIEAYNITEK (10aa)
- EAGNITTDGYEIIGK (15aa)
- MHLNGSNVQVLHR (13aa)
- RMHLNGSNVQVLHR (14aa)
Source
Suggested structure
Reference
Reported glycosite
Mass spectrometry observed peptide
Source
Disease
Reported glycosite
Source
Disease
Reported glycosite
Source
Disease
Reported glycosite
Disease
Reported glycosite
Source
Disease
Reported glycosite
Disease
Reported glycosite
Source
Disease
Reported glycosite
Source
Disease
Reported glycosite
Source
Disease
Reported glycosite
Source
Disease
Reported glycosite
Source
Disease
Reported glycosite
